Neurosciences is a premier academic journal dedicated to the exploration of neurological and psychiatric disorders, fostering an innovative exchange of ideas and research findings in these critical fields. Published by the Riyadh Armed Forces Hospital in Saudi Arabia, this interdisciplinary journal has consistently contributed to the advancement of knowledge since its inception in 2002 and is set to continue through 2024. With an ISSN of 1319-6138 and E-ISSN of 1658-3183, it is recognized for its emphasis on clinically relevant research in neurology and psychiatry, boasting a 2023 classification in the Q3 tier of both categories. Neurosciences encourages submissions that offer novel insights into mental health and neurological conditions, positioning itself as a vital resource for researchers, healthcare professionals, and students alike. Despite being unlisted as an open-access journal, it remains a respected outlet for peer-reviewed content, with Scopus rankings that highlight its growing influence within the scientific community. This journal serves as an essential platform for disseminating significant research that addresses the intricacies of the human brain and behavior.

BRAIN TOPOGRAPHY is an esteemed academic journal dedicated to the exploration of topographical mapping of brain activities, cementing its reputation as a cornerstone in the fields of anatomy, neurology, and radiology. Published by SPRINGER, this journal has been a vital resource since its inception in 1988, with a steadily increasing impact reflected in its 2023 rankings, including Q1 categories in Anatomy and Radiology. With its significant contributions to understanding cerebral structure and function through advanced imaging technology, BRAIN TOPOGRAPHY is essential for researchers, professionals, and students seeking to stay at the forefront of neuroscientific advancements. The journal benefits from its strong academic stature, positioned within the 60th to 71st percentiles across several Scopus ranks, further enhancing its visibility in an evolving research landscape. Although not an open-access journal, its rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to the scientific community. Set against the backdrop of a global landscape, this journal continues to shape discussions on cerebral topography, offering a platform for innovative studies and critical insights.

TRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.

Alpha Psychiatry, published by AVES, stands at the forefront of mental health research and psychiatric advancements. With a commitment to disseminating high-quality and impactful studies, this journal serves as a critical platform for scholars, clinicians, and students interested in exploring the complexities of psychiatric disorders and treatment methodologies. Although the impact factor and specific scope details are still evolving, Alpha Psychiatry is dedicated to fostering interdisciplinary dialogue and promoting innovative research that tackles contemporary challenges in the field of psychiatry. As an open-access journal, it ensures that research is widely accessible, enhancing knowledge transfer and collaboration within the global scientific community. Located in Istanbul, Turkiye, the journal proudly represents a rich academic tradition, aiming to contribute significantly to the global discourse on mental health.

MOLECULAR PSYCHIATRY, published by SpringerNature, is a premier peer-reviewed journal that has established itself as a leading platform for the dissemination of cutting-edge research in the fields of neuroscience, molecular biology, and psychiatry. With an impressive impact factor and a reputation for excellence, the journal is ranked Q1 in key categories, signifying its high academic quality and relevance. The journal’s scope spans groundbreaking studies and innovative therapeutic approaches that intersect at the molecular and cellular levels, providing invaluable insights into the biological underpinnings of psychiatric disorders. Since its inception in 1996, MOLECULAR PSYCHIATRY has evolved to support both established and emerging researchers, fostering a collaborative environment that enhances the understanding of mental health. It is committed to improving access to scientific knowledge, although it currently does not offer open access options. With its headquarters in London, the journal continues to play a pivotal role in enhancing the global dialogue on psychiatric and neurological advancements, making it an essential resource for academics and professionals dedicated to advancing mental health sciences.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Neuropsychologia, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal that delves into the intersections of psychology and neuroscience, specifically focusing on behavioral and cognitive processes. Since its inception in 1963, this esteemed journal has been a vital platform for researchers, professionals, and students, showcasing innovative studies and advancements in the fields of Behavioral Neuroscience, Cognitive Neuroscience, and Experimental Psychology. With a commendable impact factor, placing it in the Q2 category across multiple disciplines, Neuropsychologia is recognized for its contribution to the scientific community, ranking among the top journals in both Experimental and Cognitive Psychology and Neuroscience. The journal's commitment to excellence is evident in its rigorous peer-review process and its mission to disseminate cutting-edge research, making it an invaluable resource for those seeking to expand their knowledge and insights in neuropsychology. For further reading, the journal is accessible in both print and digital formats, ensuring that researchers can easily engage with the latest findings and theoretical advancements in this dynamic field.

Journal of Experimental Psychopathology, published by SAGE Publications Ltd, stands as a pivotal platform for advancing the understanding of psychological disorders and their underlying mechanisms. Established in 2015, this open access journal encourages a broad dissemination of research findings, adhering to its mission to foster innovation in the fields of Clinical Psychology and Psychiatry and Mental Health. With an established impact recognized in its Q3 quartile rankings for both fields as of 2023, the journal aims to bridge the gap between experimental research and clinical application. Researchers, professionals, and students are invited to engage with cutting-edge studies, all while benefiting from the journal's commitment to open access publishing since 2018, ensuring that knowledge is easily accessible to all. The journal’s office is strategically located in London, UK, serving a global academic community keen on exploring the complexities of psychopathology.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, published by Elsevier, is a prestigious academic journal that serves as a cornerstone in the field of neuropsychopharmacology, embracing multidisciplinary research at the intersection of neuroscience, psychiatry, and pharmacology. Since its establishment in 1990, this journal has consistently delivered cutting-edge research and reviews that drive forward our understanding of central nervous system disorders and their treatment. With an impressive impact factor and ranked in the Q1 category for several disciplines, including Biological Psychiatry and Neurology, it attracts submissions from leading researchers globally. The journal’s Scopus rankings reflect its significant influence, ranking in the top echelons across various categories such as Medicine and Neuroscience. While the journal maintains subscription access, readers are encouraged to explore the breadth of important findings that contribute to advancements in treatment options and improve patient care. EUROPEAN NEUROPSYCHOPHARMACOLOGY not only supports the dissemination of pivotal research but also fosters collaboration and dialogue within the scientific community, making it an essential resource for researchers, clinicians, and students dedicated to the complexities of brain health.

PSYCHOPHYSIOLOGY, published by WILEY, stands as a leading journal in the intersection of psychology and physiology, contributing significantly to our understanding of the brain and body connection since its inception in 1964. With an impressive scope covering areas such as biological psychiatry, cognitive neuroscience, and neuropsychology among others, the journal has earned multiple Q1 rankings in these critical domains as of 2023, reflecting its high impact in the field. The journal ranks particularly well in categories such as Experimental and Cognitive Psychology and neurology, indicating its status as a pivotal resource for professionals and researchers committed to advancing knowledge in psychophysiological studies. Furthermore, with an e-ISSN of 1469-8986, PSYCHOPHYSIOLOGY is accessible to a global audience, although it is not part of the Open Access movement, ensuring that its rigorous research remains a trusted source for academic excellence. By engaging with this journal, readers can expect to discover pioneering research and significant findings that push the boundaries of current understanding, making it an essential publication for those invested in the advancements of psychological and physiological sciences.